Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 428.1% in December

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 15th total of 12,100 shares. Based on an average daily trading volume, of 124,300 shares, the days-to-cover ratio is presently 0.5 days.

Fresenius SE & Co. KGaA Price Performance

Shares of OTCMKTS:FSNUY traded down $0.12 on Monday, reaching $8.89. 85,939 shares of the company were exchanged, compared to its average volume of 127,662. The company has a current ratio of 1.36, a quick ratio of 1.05 and a debt-to-equity ratio of 0.57. Fresenius SE & Co. KGaA has a 1-year low of $6.57 and a 1-year high of $9.78. The company has a 50-day moving average of $8.87 and a 200-day moving average of $8.88. The firm has a market cap of $19.86 billion, a price-to-earnings ratio of 12.36 and a beta of 1.02.

Analyst Upgrades and Downgrades

Separately, Citigroup upgraded shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.